<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:689d399f-7379-4cad-9769-304a2738618d,g:0970e8f7-af8a-4351-9762-e5c05b3985c9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="rnac-20240630.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_94526c2b-45b9-4c57-992f-4c20769e6593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_94526c2b-45b9-4c57-992f-4c20769e6593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b507fc16-9691-41af-9617-2241d5148844" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_Goodwill_b507fc16-9691-41af-9617-2241d5148844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f85c20a1-b040-484f-9e16-8add46543a37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_f85c20a1-b040-484f-9e16-8add46543a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_e64c4b1c-51f2-423b-b353-59dee79f4110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_e64c4b1c-51f2-423b-b353-59dee79f4110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dbbbfe64-97ef-45b1-acd6-bf4f6b547717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_dbbbfe64-97ef-45b1-acd6-bf4f6b547717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_407526d3-7fd7-43ac-8f7d-750a5ec0c62d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_407526d3-7fd7-43ac-8f7d-750a5ec0c62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fc5fdad0-817d-4a67-952b-95a227be8b26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f25fa342-19c4-4269-aff9-f3b24ea032c1" xlink:to="loc_us-gaap_AssetsCurrent_fc5fdad0-817d-4a67-952b-95a227be8b26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_901722d0-9dbc-4e58-b8b3-170cceae02fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:to="loc_us-gaap_CommonStockValue_901722d0-9dbc-4e58-b8b3-170cceae02fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_76c17f5d-6686-4334-a6a6-91f1572496d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_76c17f5d-6686-4334-a6a6-91f1572496d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cb00d2b9-56e8-4ee6-94d9-5df1a0386449" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:to="loc_us-gaap_PreferredStockValue_cb00d2b9-56e8-4ee6-94d9-5df1a0386449" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42fb06a4-84bf-4f18-bca0-bc54ee4f6dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42fb06a4-84bf-4f18-bca0-bc54ee4f6dcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ed7d5441-2c9c-48b7-95a8-74b2c9dac91c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_5bbaec3d-51fb-43bd-86ac-4ed5cda509bb" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ed7d5441-2c9c-48b7-95a8-74b2c9dac91c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa74674c-f341-422d-9273-65bb66f24229" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fa74674c-f341-422d-9273-65bb66f24229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6d9fa41a-c2ff-4090-b113-0b1a8654bfc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6d9fa41a-c2ff-4090-b113-0b1a8654bfc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_dc17dc33-40f0-445f-9b7c-1a87803b0f06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_us-gaap_LiabilitiesCurrent_dc17dc33-40f0-445f-9b7c-1a87803b0f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityNoncurrent_270250ba-5d0c-4abb-ab0c-c8453036a5e8" xlink:href="rnac-20240630.xsd#rnac_ContingentValueRightLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_rnac_ContingentValueRightLiabilityNoncurrent_270250ba-5d0c-4abb-ab0c-c8453036a5e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_479202b8-b8fd-4895-9da4-2733dcdd8bf5" xlink:href="rnac-20240630.xsd#rnac_WarrantsAndRightsOutstandingNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_rnac_WarrantsAndRightsOutstandingNoncurrent_479202b8-b8fd-4895-9da4-2733dcdd8bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e054be67-488c-4513-ab50-1d9603540d51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0506c2fb-957f-4793-b6e0-80f0e0a98532" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_e054be67-488c-4513-ab50-1d9603540d51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_92136763-8bb2-4e77-be2c-d7c72cfc35f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_92136763-8bb2-4e77-be2c-d7c72cfc35f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_WarrantsAndRightsOutstandingCurrent_fd20383d-138e-4103-8d3d-821b64d0775e" xlink:href="rnac-20240630.xsd#rnac_WarrantsAndRightsOutstandingCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_rnac_WarrantsAndRightsOutstandingCurrent_fd20383d-138e-4103-8d3d-821b64d0775e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a500956d-62af-43b8-888e-f77811ab584d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_us-gaap_AccountsPayableCurrent_a500956d-62af-43b8-888e-f77811ab584d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_8b12658e-e7e5-4251-9154-e3140d7472f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_8b12658e-e7e5-4251-9154-e3140d7472f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8db3fa0e-7ead-4969-a940-806937119e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_8db3fa0e-7ead-4969-a940-806937119e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiabilityCurrent_f4b138fd-7003-4ca7-a46c-e133e9d525b1" xlink:href="rnac-20240630.xsd#rnac_ContingentValueRightLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_rnac_ContingentValueRightLiabilityCurrent_f4b138fd-7003-4ca7-a46c-e133e9d525b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3f6dd121-2973-4eb3-983c-d71706b9bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_502d59dd-f6db-45fa-9ae6-efd8e1f9dd8c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3f6dd121-2973-4eb3-983c-d71706b9bd74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_31919958-3a51-46c4-a9a2-6a3342690e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_31919958-3a51-46c4-a9a2-6a3342690e1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_615f1bd9-f90d-40f3-a475-25669d4b40e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:to="loc_us-gaap_Liabilities_615f1bd9-f90d-40f3-a475-25669d4b40e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent_bf879cbe-978c-42d5-a6be-db14d4a251bd" xlink:href="rnac-20240630.xsd#rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:to="loc_rnac_TemporaryEquityOptionsCarryingAmountAttributableToParent_bf879cbe-978c-42d5-a6be-db14d4a251bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b0a145a-ace0-46ae-acd4-aa9960ded4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:to="loc_us-gaap_StockholdersEquity_4b0a145a-ace0-46ae-acd4-aa9960ded4c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d5985ce3-b9bc-4730-b0ea-95a590487c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1a813188-5703-48d1-9090-02d29f0a4d38" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d5985ce3-b9bc-4730-b0ea-95a590487c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_01d654ed-07d2-4671-9534-6fb313b7a475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_afee302f-08cf-459b-a81e-a5495d47dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01d654ed-07d2-4671-9534-6fb313b7a475" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_afee302f-08cf-459b-a81e-a5495d47dec1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_b00cbb1e-b69f-4963-8579-b1176943ff49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01d654ed-07d2-4671-9534-6fb313b7a475" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_b00cbb1e-b69f-4963-8579-b1176943ff49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8472503f-b322-43cb-bf5d-5c9a9168c488" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01d654ed-07d2-4671-9534-6fb313b7a475" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8472503f-b322-43cb-bf5d-5c9a9168c488" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_03b7e609-7072-483e-be38-fdd82c5a8f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_01d654ed-07d2-4671-9534-6fb313b7a475" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_03b7e609-7072-483e-be38-fdd82c5a8f69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="rnac-20240630.xsd#ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0689f0c1-317b-4114-9cb7-da73b0cfcc28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_51fc1d0b-e215-4fa6-aec6-626f52182f26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0689f0c1-317b-4114-9cb7-da73b0cfcc28" xlink:to="loc_us-gaap_NetIncomeLoss_51fc1d0b-e215-4fa6-aec6-626f52182f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_5ba8bdcc-64af-46d7-a24a-82d41eed1ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_0689f0c1-317b-4114-9cb7-da73b0cfcc28" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_5ba8bdcc-64af-46d7-a24a-82d41eed1ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_08da181d-8ffe-4c48-8257-3d3f3ec9ccf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35c3801-2ac6-4595-9aec-db2dc6514631" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_08da181d-8ffe-4c48-8257-3d3f3ec9ccf4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c35c3801-2ac6-4595-9aec-db2dc6514631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_7a10877a-11e5-49e2-8039-0aeea3b8e431" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_08da181d-8ffe-4c48-8257-3d3f3ec9ccf4" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_7a10877a-11e5-49e2-8039-0aeea3b8e431" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_704563ab-f554-46b8-bfa3-8713b44cfeec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee74543f-7321-4dd8-aceb-d88236acdb20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_704563ab-f554-46b8-bfa3-8713b44cfeec" xlink:to="loc_us-gaap_NetIncomeLoss_ee74543f-7321-4dd8-aceb-d88236acdb20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_49f567ca-ae76-48d1-ac04-d731099648f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_704563ab-f554-46b8-bfa3-8713b44cfeec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_49f567ca-ae76-48d1-ac04-d731099648f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0ed518f2-99af-4a66-b857-2d1d6e5b81e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_704563ab-f554-46b8-bfa3-8713b44cfeec" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0ed518f2-99af-4a66-b857-2d1d6e5b81e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dcabc845-c976-4d4f-ba9f-e4f399a5532e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b2af1037-58ea-466f-b3d2-6e0724e8351d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dcabc845-c976-4d4f-ba9f-e4f399a5532e" xlink:to="loc_us-gaap_NetIncomeLoss_b2af1037-58ea-466f-b3d2-6e0724e8351d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_22ab8ff5-50b9-43a3-bae6-d5ee2a6ae49a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dcabc845-c976-4d4f-ba9f-e4f399a5532e" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_22ab8ff5-50b9-43a3-bae6-d5ee2a6ae49a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d3e04330-a9a7-4951-b6e1-0d137adedc89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_eebed6ca-1b44-470e-aea9-57f17c75ad4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d3e04330-a9a7-4951-b6e1-0d137adedc89" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_eebed6ca-1b44-470e-aea9-57f17c75ad4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b024d077-adca-4073-9f63-5a03c5134472" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_d3e04330-a9a7-4951-b6e1-0d137adedc89" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b024d077-adca-4073-9f63-5a03c5134472" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_28f7ba2f-ba5f-454a-9b7c-95865ae8111a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_28f7ba2f-ba5f-454a-9b7c-95865ae8111a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ca5d4636-e78f-4597-a4eb-4f1fb49ae020" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_ca5d4636-e78f-4597-a4eb-4f1fb49ae020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_5d24a9e3-de5b-4317-89e5-8d348658278e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_5d24a9e3-de5b-4317-89e5-8d348658278e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6a7fe51c-a7c0-4f74-96c7-7ad400e366c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_OperatingIncomeLoss_6a7fe51c-a7c0-4f74-96c7-7ad400e366c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3355fbd0-38c6-4199-b6e4-c073f2122429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3355fbd0-38c6-4199-b6e4-c073f2122429" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_244ce312-6037-4067-aaf9-1c3159e3403c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_InvestmentIncomeNet_244ce312-6037-4067-aaf9-1c3159e3403c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_e8222c18-6c4c-403e-a222-482094915881" xlink:href="rnac-20240630.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_e8222c18-6c4c-403e-a222-482094915881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_d9e8ad13-bc39-4ed4-bfa2-f4e660fe36ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3c0e8c77-0fd8-4ce3-a587-eef3ab4c3070" xlink:to="loc_us-gaap_InterestExpenseNonoperating_d9e8ad13-bc39-4ed4-bfa2-f4e660fe36ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5157e863-28a5-4a24-a863-579ebb3a3a88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_41e4ee0b-f885-4716-b02d-fefba6e244a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5157e863-28a5-4a24-a863-579ebb3a3a88" xlink:to="loc_us-gaap_OperatingExpenses_41e4ee0b-f885-4716-b02d-fefba6e244a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_861d0299-130b-48e6-8f9b-c938737ed433" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5157e863-28a5-4a24-a863-579ebb3a3a88" xlink:to="loc_us-gaap_Revenues_861d0299-130b-48e6-8f9b-c938737ed433" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="rnac-20240630.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_dd023d2d-fbc3-4f41-95b9-e19bfca45f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_dd023d2d-fbc3-4f41-95b9-e19bfca45f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_9da93c45-1812-4636-9fd5-e9b44d144590" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:to="loc_us-gaap_ProceedsFromStockPlans_9da93c45-1812-4636-9fd5-e9b44d144590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_8b60f7fe-afb6-4ce5-8a7b-4807a46626d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_8b60f7fe-afb6-4ce5-8a7b-4807a46626d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_af77fb77-6de9-4154-92d5-e56921826b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_af77fb77-6de9-4154-92d5-e56921826b6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_204d9e5a-1c24-4e90-a60d-5a113b3cf6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4baa55-311a-46ac-9270-d07542822b2e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_204d9e5a-1c24-4e90-a60d-5a113b3cf6a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_54ed263d-0998-47ab-a0a3-19984f200c0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_54ed263d-0998-47ab-a0a3-19984f200c0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_3006ccce-18e2-4470-8030-3ca34bee973b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_3006ccce-18e2-4470-8030-3ca34bee973b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_41b272d6-4290-465a-9a09-6d7ef6f10cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_41b272d6-4290-465a-9a09-6d7ef6f10cfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d346e082-3b5c-40f2-afde-b672586db624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d346e082-3b5c-40f2-afde-b672586db624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_65d6ac24-7827-44f1-9758-c39f3328777d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_NetIncomeLoss_65d6ac24-7827-44f1-9758-c39f3328777d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e0bedbf1-7454-4591-b987-79b539203d09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e0bedbf1-7454-4591-b987-79b539203d09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6f236d09-a1e7-4ef9-8992-87cfa2168876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6f236d09-a1e7-4ef9-8992-87cfa2168876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_bbc2998f-07f9-4d17-b9c0-eb42df784315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_bbc2998f-07f9-4d17-b9c0-eb42df784315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_565e809d-71cd-40b9-964c-36198db055e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_ShareBasedCompensation_565e809d-71cd-40b9-964c-36198db055e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDepreciationAndAmortization_d6afed2f-2f8f-4c9b-a653-379ebf33d500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDepreciationAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_OtherDepreciationAndAmortization_d6afed2f-2f8f-4c9b-a653-379ebf33d500" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_78203cde-a20e-4ec0-bc13-4f448922b0d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_78203cde-a20e-4ec0-bc13-4f448922b0d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_69c28b7e-859e-4359-881a-bd80201dc330" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_69c28b7e-859e-4359-881a-bd80201dc330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_1e9040d2-d064-41a8-a9ee-22804ad53c25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_PaidInKindInterest_1e9040d2-d064-41a8-a9ee-22804ad53c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_462e9096-d66f-42d4-8c23-b558adc81d5f" xlink:href="rnac-20240630.xsd#rnac_FairValueAdjustmentOfContingentValueRightLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_rnac_FairValueAdjustmentOfContingentValueRightLiability_462e9096-d66f-42d4-8c23-b558adc81d5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_2d9eb75d-0dff-4a76-8fce-7b924a2df062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_2d9eb75d-0dff-4a76-8fce-7b924a2df062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_64335780-b621-4021-843e-9a4ee5c1e4eb" xlink:href="rnac-20240630.xsd#rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f82cf332-8b63-4fe9-ae3f-404c5e8f2157" xlink:to="loc_rnac_IncreaseDecreaseInContractWithCustomerAssetAllowanceForCreditLossCurrent_64335780-b621-4021-843e-9a4ee5c1e4eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3c4e42f-2036-4ceb-ace6-705d9504e2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_93415632-7eb1-4480-9054-8b0acbe8b495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3c4e42f-2036-4ceb-ace6-705d9504e2c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_93415632-7eb1-4480-9054-8b0acbe8b495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_070bba3b-94b9-4c17-a086-b28673b3d749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3c4e42f-2036-4ceb-ace6-705d9504e2c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_070bba3b-94b9-4c17-a086-b28673b3d749" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_683a035b-ce85-4bee-8999-06ce8b837c94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3c4e42f-2036-4ceb-ace6-705d9504e2c9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_683a035b-ce85-4bee-8999-06ce8b837c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d3b6d9d-435a-45bb-a471-113b6a5124e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d3c4e42f-2036-4ceb-ace6-705d9504e2c9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d3b6d9d-435a-45bb-a471-113b6a5124e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8a66753-4457-4c65-8fa5-71c4ce0e5519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_ba0d097c-4912-4f50-ac39-322fc241432c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8a66753-4457-4c65-8fa5-71c4ce0e5519" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_ba0d097c-4912-4f50-ac39-322fc241432c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2fac7f48-2925-4e10-ba85-64a23a2020ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d8a66753-4457-4c65-8fa5-71c4ce0e5519" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2fac7f48-2925-4e10-ba85-64a23a2020ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/MergerScheduleofFairValueofConsiderationDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#MergerScheduleofFairValueofConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/MergerScheduleofFairValueofConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1f787f89-585d-475c-aa97-576a6499aac6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_186a0326-c97c-4f94-a01e-d5fef2f83879" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1f787f89-585d-475c-aa97-576a6499aac6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_186a0326-c97c-4f94-a01e-d5fef2f83879" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/MergerScheduleofAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73e11172-f520-43e7-a7be-6d42f89dc605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities_9d8d481f-244e-458c-b9ed-fa27d38190f2" xlink:href="rnac-20240630.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73e11172-f520-43e7-a7be-6d42f89dc605" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities_9d8d481f-244e-458c-b9ed-fa27d38190f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ae77c37f-7a8c-403b-9001-ec1f474aa49d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73e11172-f520-43e7-a7be-6d42f89dc605" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ae77c37f-7a8c-403b-9001-ec1f474aa49d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability_a7818dc5-b37c-4f0d-8fc0-e371a4fed788" xlink:href="rnac-20240630.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73e11172-f520-43e7-a7be-6d42f89dc605" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLeaseLiability_a7818dc5-b37c-4f0d-8fc0-e371a4fed788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability_a94e6797-3fbf-4fb5-8995-fc9ae0a89e49" xlink:href="rnac-20240630.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_73e11172-f520-43e7-a7be-6d42f89dc605" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLeaseLiability_a94e6797-3fbf-4fb5-8995-fc9ae0a89e49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_41b86cf2-4750-4501-bbf0-20add9544f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_us-gaap_Goodwill_41b86cf2-4750-4501-bbf0-20add9544f1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_56f1b0d6-3874-42cd-bc9b-771505d63267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_56f1b0d6-3874-42cd-bc9b-771505d63267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c45c3c1f-1c47-4783-b2ed-3610e274e891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c45c3c1f-1c47-4783-b2ed-3610e274e891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_e6d386c5-3f9e-48cc-ae6f-a874e4d49608" xlink:href="rnac-20240630.xsd#rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_rnac_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAsset_e6d386c5-3f9e-48cc-ae6f-a874e4d49608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_98034f64-5e09-4719-b09c-d33c5eeb4365" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_98034f64-5e09-4719-b09c-d33c5eeb4365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_73a32259-1da6-499c-b761-d2415827960c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_89424ef2-4b82-4761-9058-5e570b2f6e28" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_73a32259-1da6-499c-b761-d2415827960c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22289f48-788e-4326-b637-fb689d50f4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_286322fa-9453-499b-940c-b38137bd5760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22289f48-788e-4326-b637-fb689d50f4ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_286322fa-9453-499b-940c-b38137bd5760" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b1dec4e1-c08b-47c6-a617-6b903026fb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22289f48-788e-4326-b637-fb689d50f4ca" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b1dec4e1-c08b-47c6-a617-6b903026fb0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/NetIncomeLossPerShareAllocabletoCommonStockholdersComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#NetIncomeLossPerShareAllocabletoCommonStockholdersComputationofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/NetIncomeLossPerShareAllocabletoCommonStockholdersComputationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a8d666b-2a12-4a65-a928-509525d83159" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6282d194-5728-4446-bedb-b551630eaa41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a8d666b-2a12-4a65-a928-509525d83159" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6282d194-5728-4446-bedb-b551630eaa41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e765eaa6-eb94-44c1-917f-84a7f1fd51b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a8d666b-2a12-4a65-a928-509525d83159" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e765eaa6-eb94-44c1-917f-84a7f1fd51b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofAssetsMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_870fd92d-2e9a-48f8-84d8-d82d721d7319" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5f74f27f-3ae4-4bc7-8ac1-180f06bcf1c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_870fd92d-2e9a-48f8-84d8-d82d721d7319" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5f74f27f-3ae4-4bc7-8ac1-180f06bcf1c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_e7efd03c-5952-42fb-8882-26eb912153aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1e46f35d-9ca9-4b78-9fdb-6ccf836d7079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e7efd03c-5952-42fb-8882-26eb912153aa" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1e46f35d-9ca9-4b78-9fdb-6ccf836d7079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_4e2d6a7d-6953-4432-a127-6caa7f205fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e7efd03c-5952-42fb-8882-26eb912153aa" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_4e2d6a7d-6953-4432-a127-6caa7f205fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContingentValueRightLiability_30e9c404-18aa-4a5d-b346-e1084790d75c" xlink:href="rnac-20240630.xsd#rnac_ContingentValueRightLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_e7efd03c-5952-42fb-8882-26eb912153aa" xlink:to="loc_rnac_ContingentValueRightLiability_30e9c404-18aa-4a5d-b346-e1084790d75c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#FairValueMeasurementsScheduleofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/FairValueMeasurementsScheduleofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17abcf24-6fcb-4252-8978-d903f786db4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_d24cf84a-8573-4ae3-b7b4-2b1c155533cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17abcf24-6fcb-4252-8978-d903f786db4c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_d24cf84a-8573-4ae3-b7b4-2b1c155533cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_48b0e138-b8da-4574-beb3-452bf9b0b382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17abcf24-6fcb-4252-8978-d903f786db4c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_48b0e138-b8da-4574-beb3-452bf9b0b382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62b6b973-885f-44e6-82ea-c3e41a641c09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_17abcf24-6fcb-4252-8978-d903f786db4c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_62b6b973-885f-44e6-82ea-c3e41a641c09" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#PropertyandEquipmentScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/PropertyandEquipmentScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e9c1c256-4ff1-4793-985a-60e77fa91057" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_64d8c393-c189-486f-88b0-0d382508f5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e9c1c256-4ff1-4793-985a-60e77fa91057" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_64d8c393-c189-486f-88b0-0d382508f5b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ed8cd150-2521-4489-b6cd-3d52893190a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e9c1c256-4ff1-4793-985a-60e77fa91057" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ed8cd150-2521-4489-b6cd-3d52893190a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_abf85b83-2c98-4a8b-871e-7b889aa55bca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_abf85b83-2c98-4a8b-871e-7b889aa55bca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_34cd5aaa-9592-450a-8781-65fe61a761fd" xlink:href="rnac-20240630.xsd#rnac_AccruedResearchAndDevelopmentCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_rnac_AccruedResearchAndDevelopmentCostsCurrent_34cd5aaa-9592-450a-8781-65fe61a761fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPropertyPlantAndEquipmentCurrent_a58c585b-b8a1-4efa-8c08-91c972337c8b" xlink:href="rnac-20240630.xsd#rnac_AccruedPropertyPlantAndEquipmentCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_rnac_AccruedPropertyPlantAndEquipmentCurrent_a58c585b-b8a1-4efa-8c08-91c972337c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedAuditFeesCurrent_3022a6ad-909f-4f3f-b7f8-61c5727d0854" xlink:href="rnac-20240630.xsd#rnac_AccruedAuditFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_rnac_AccruedAuditFeesCurrent_3022a6ad-909f-4f3f-b7f8-61c5727d0854" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_AccruedPatentFeesCurrent_a0dd145e-e8f6-4090-8eed-ac0c6400f804" xlink:href="rnac-20240630.xsd#rnac_AccruedPatentFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_rnac_AccruedPatentFeesCurrent_a0dd145e-e8f6-4090-8eed-ac0c6400f804" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_70f4d993-a007-4994-9844-8931dd54ff71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_eb8a66bd-1479-475f-b8cd-e5ce4dcd927b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_70f4d993-a007-4994-9844-8931dd54ff71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#LeasesComponentsofLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesComponentsofLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_12a7be67-543b-4a42-9918-1d8e7777302d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_315f580a-e8c4-46b2-8648-2c3585593385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_12a7be67-543b-4a42-9918-1d8e7777302d" xlink:to="loc_us-gaap_OperatingLeaseCost_315f580a-e8c4-46b2-8648-2c3585593385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_b70149c1-2bba-47f3-b16a-02d2137236b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_12a7be67-543b-4a42-9918-1d8e7777302d" xlink:to="loc_us-gaap_VariableLeaseCost_b70149c1-2bba-47f3-b16a-02d2137236b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_c58def4f-197f-4de3-93b9-80b129b755eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_12a7be67-543b-4a42-9918-1d8e7777302d" xlink:to="loc_us-gaap_ShortTermLeaseCost_c58def4f-197f-4de3-93b9-80b129b755eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_4ce32960-e446-418e-ba5b-be219dc74b73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_12a7be67-543b-4a42-9918-1d8e7777302d" xlink:to="loc_us-gaap_SubleaseIncome_4ce32960-e446-418e-ba5b-be219dc74b73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#LeasesOperatingLeaseLiabilityMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cd788da9-e310-4a7b-94d9-77798424c4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7eb0e481-b0e1-4a80-917c-bf26f9195d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cd788da9-e310-4a7b-94d9-77798424c4ba" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7eb0e481-b0e1-4a80-917c-bf26f9195d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8be5c8ce-1940-40e3-a8bd-f41d7bc9aaa7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_cd788da9-e310-4a7b-94d9-77798424c4ba" xlink:to="loc_us-gaap_OperatingLeaseLiability_8be5c8ce-1940-40e3-a8bd-f41d7bc9aaa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails_1" xlink:type="simple" xlink:href="rnac-20240630.xsd#LeasesOperatingLeaseLiabilityMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/LeasesOperatingLeaseLiabilityMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d1c1a181-97e7-484a-9148-cd80cf4c1d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_d1c1a181-97e7-484a-9148-cd80cf4c1d8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_273c7ad6-bda9-4867-b36c-73cb40d56bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_273c7ad6-bda9-4867-b36c-73cb40d56bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1d2808ee-ab3a-497f-9640-b85c399e4e82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1d2808ee-ab3a-497f-9640-b85c399e4e82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_668f65cb-351c-431b-b6ff-5830f59b7623" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_668f65cb-351c-431b-b6ff-5830f59b7623" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0e6ce28c-ceb6-4cb2-95c1-684c9b28c563" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0e6ce28c-ceb6-4cb2-95c1-684c9b28c563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_dd73f5a5-6b93-4ab4-b0b4-fc85adc3043c" xlink:href="rnac-20240630.xsd#rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_920a57df-d768-41ff-98bf-2fa636d1534b" xlink:to="loc_rnac_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_dd73f5a5-6b93-4ab4-b0b4-fc85adc3043c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cartesiantherapeutics.com/role/RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails" xlink:type="simple" xlink:href="rnac-20240630.xsd#RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cartesiantherapeutics.com/role/RevenueArrangementsScheduleofChangesinContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ab834909-f08d-4ffb-8ee2-7baaf3099ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractWithCustomerLiabilityDeferredRevenue_1cb3df82-1f78-4c34-8582-4cf682be2003" xlink:href="rnac-20240630.xsd#rnac_ContractWithCustomerLiabilityDeferredRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiability_ab834909-f08d-4ffb-8ee2-7baaf3099ee6" xlink:to="loc_rnac_ContractWithCustomerLiabilityDeferredRevenue_1cb3df82-1f78-4c34-8582-4cf682be2003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_16574bed-ee68-43ba-b5d2-10912768ba83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractWithCustomerLiabilityDeferredRevenueRevenueRecognized_2b3888df-d4bf-45d1-8279-5c5a112ab6cd" xlink:href="rnac-20240630.xsd#rnac_ContractWithCustomerLiabilityDeferredRevenueRevenueRecognized"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_16574bed-ee68-43ba-b5d2-10912768ba83" xlink:to="loc_rnac_ContractWithCustomerLiabilityDeferredRevenueRevenueRecognized_2b3888df-d4bf-45d1-8279-5c5a112ab6cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractWithCustomerLiabilityIncreaseFromCashReceipts_99f9b7d8-c027-435b-a662-526c8a017417" xlink:href="rnac-20240630.xsd#rnac_ContractWithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:loc xlink:type="locator" xlink:label="loc_rnac_ContractWithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts_ccc0f949-02e5-4df4-b62c-2b34c885ab8e" xlink:href="rnac-20240630.xsd#rnac_ContractWithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rnac_ContractWithCustomerLiabilityIncreaseFromCashReceipts_99f9b7d8-c027-435b-a662-526c8a017417" xlink:to="loc_rnac_ContractWithCustomerLiabilityDeferredRevenueIncreaseFromCashReceipts_ccc0f949-02e5-4df4-b62c-2b34c885ab8e" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
